Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
5.29
+0.78 (17.29%)
At close: Dec 26, 2024, 4:00 PM
5.32
+0.03 (0.57%)
After-hours: Dec 26, 2024, 4:24 PM EST
Humacyte Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Humacyte stock have an average target of 13.43, with a low estimate of 4.00 and a high estimate of 25. The average target predicts an increase of 153.88% from the current stock price of 5.29.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +221.36% | Dec 23, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +372.59% | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 → $15 | Strong Buy | Reiterates | $12 → $15 | +183.55% | Dec 20, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +372.59% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +126.84% | Nov 18, 2024 |
Financial Forecast
Revenue This Year
218.58K
Revenue Next Year
14.29M
from 218.58K
Increased by 6,438.24%
EPS This Year
-1.38
from -1.07
EPS Next Year
-0.88
from -1.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.6M | 31.8M | 308.0M | |||
| Avg | 218,576 | 14.3M | 126.5M | |||
| Low | n/a | 2.6M | 49.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 14,455.6% | 2,054.9% | |||
| Avg | - | 6,438.2% | 784.8% | |||
| Low | - | 1,110.6% | 242.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.39 | -0.71 | 1.26 | |||
| Avg | -1.38 | -0.88 | -0.19 | |||
| Low | -1.38 | -1.10 | -0.62 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.